Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Getting to know the iShares Global Healthcare ETF (ASX:IXJ)

Healthcare has been one of the main talking points of 2020. The iShares Global Healthcare ETF (ASX: IXJ) is one way to get exposure to this growing sector, so what's actually in it?

Healthcare has obviously been one of the main talking points of 2020. The iShares Global Healthcare ETF (ASX: IXJ) is one way to get exposure to this growing sector, so what’s actually in it?

Sector ETFs

Firstly, the IXJ ETF is a sector ETF. Sector ETFs focus on one of the Global Industry Classification Standard (GICS) sectors.

There are 11 GICS sectors and many smaller industries and sub-industries within these sectors. Some of the sectors include financials, energy, information technology, and healthcare.

Every listed company is categorised into one of the sectors. Therefore, a sector ETF will invest only in companies in a certain category.

Unpacking the iShares Global Healthcare ETF

The iShares Global Healthcare ETF invests in more than 100 healthcare companies around the world. These companies are involved in things like pharmaceuticals, biotechnology and the supply of medical equipment. As of July 2020, some of IXJ’s top holdings include Johnson & JohnsonNovartisPfizer, and UnitedHealth Group.

Around 70% of the ETF is made up of US-based companies, but there is also exposure to Switzerland, Japan, the UK, Denmark, Germany, and others.

The healthcare sector has a number of tailwinds at its back. Globally, we have a growing and ageing population that will start to require greater amounts of care. The sector is also experiencing rapid growth in the use of technology to handle administrative tasks and data analysis, which makes the industry more efficient.

Looking to performance, the IXJ ETF has a long track record and has delivered growth of 15.97% per year over the last 10 years (although this is not indicative of future performance).

Fees & risks

The IXJ ETF charges a management fee of 0.47% per year. In terms of risks, the most obvious risk is the lack of diversification. While IXJ holds companies across several sub-sectors, they are all within the healthcare sector and will typically demonstrate a high correlation to each other.

Sector ETFs may be more suitable as a ‘satellite’ holding rather than a core holding; a small portion of your overall portfolio which is allocated to high-conviction and high-growth ideas.

Another risk is the price of the healthcare companies within the portfolio. Using the iShares S&P 500 ETF (ASX: IVV) as a comparison, IVV has a P/E ratio of 21.9 compared to 26 for IXJ. The healthcare ETF also has a higher price-to-book ratio.

This suggests that, in general, healthcare companies are priced more optimistically than the overall market which could limit future share price growth.

To read more about IXJ, check out our free report here.

And if you’re interested in investing in ETFs but aren’t sure where to start, our free Beginner’s ETF Investing Course is a great way to get up to speed.

[ls_content_block id=”14947″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Disclosure: At the time of publishing, Max owns units in the iShares S&P 500 ETF (ASX:IVV).
Skip to content